HMG CoA reductase inhibitors.

  title={HMG CoA reductase inhibitors.},
  author={Giso Feussner},
  journal={Current opinion in lipidology},
  volume={5 1},
Beta-hydroxy-beta-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors (HMG CoA RIs) are now being prescribed in many different countries, and the number of patients treated with these compounds is estimated to be over 1.5 million. The spectrum of indications for these drugs is enlarging. Thus, not only patients with primary hypercholesterolemia are suitable candidates for therapy with HMG CoA RIs, but also patients with other forms of familial and non-familial (secondary) dyslipidemias… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-8 of 8 extracted citations

Similar Papers

Loading similar papers…